The kizuna centrosomal protein, known by the gene symbol KIZ or C2orf39, is an important protein associated with the centrosome in cells. The centrosome is a key cellular structure that plays a crucial role in organizing microtubules and is critical for the process of cell division (mitosis). Kizuna is particularly vital during the mitotic phase, where it helps maintain the integrity of the centrosome and ensures proper mitotic spindle formation.This protein was dubbed "kizuna" because the term means "bonds" in Japanese, reflecting its function in maintaining the cohesive structure of the centrosome during the stressful conditions of cell division. Just as kizuna signifies strong social bonds or ties between people, the kizuna protein helps maintain the structural cohesion between centrioles, the cylindrical structures that comprise the centrosome.
Mutations or dysfunctions in the KIZ gene or the kizuna protein can lead to errors in cell division, which may have implications for various diseases, including cancer, where cell division becomes unregulated. Additionally, proper centrosomal function is crucial for the development and maintenance of organismal complexity, so alterations in proteins like kizuna can have significant developmental consequences.Kizuna's role extends beyond simply holding the centrosome together; it is also involved in the recruitment of other proteins to the centrosome and can influence the timing of cell cycle progression.
VER TAMBIÉN ....
| Nombre del producto | NÚMERO DE CAS # | Número de catálogo | Cantidad | Precio | MENCIONES | Clasificación |
|---|---|---|---|---|---|---|
BI6727 | 755038-65-4 | sc-364432 sc-364432A sc-364432B sc-364432C sc-364432D | 5 mg 50 mg 100 mg 500 mg 1 g | $147.00 $1029.00 $1632.00 $3264.00 $4296.00 | 1 | |
BI 2536 es un inhibidor de PLK1. Aunque inhibe PLK1, puede influir indirectamente en la interacción de la Proteína Centrosomal Kizuna con PLK1. | ||||||
BI 2536 | 755038-02-9 | sc-364431 sc-364431A | 5 mg 50 mg | $148.00 $515.00 | 8 | |
Volasertib es otro inhibidor de PLK1, que puede afectar a los procesos en los que interactúan la proteína centrosomal Kizuna y PLK1. | ||||||
GSK461364 | 929095-18-1 | sc-364504 sc-364504A | 10 mg 50 mg | $500.00 $1540.00 | ||
GSK461364 es un inhibidor selectivo de PLK1, posiblemente impactando la función de la Proteína Centrosomal Kizuna indirectamente a través de la modulación de PLK1. | ||||||
NVP-BHG712 | 940310-85-0 | sc-364554 sc-364554A | 5 mg 50 mg | $232.00 $1764.00 | ||
GW843682X es un inhibidor de PLK1, que puede modular indirectamente la función de la Proteína Centrosomal Kizuna influyendo en PLK1. | ||||||
RO-3306 | 872573-93-8 | sc-358700 sc-358700A sc-358700B | 1 mg 5 mg 25 mg | $65.00 $160.00 $320.00 | 37 | |
RO3280 es un inhibidor de PLK1, que podría tener un impacto indirecto sobre la Proteína Centrosomal Kizuna a través de la modulación de la vía PLK1. | ||||||
LFM-A13 | 62004-35-7 | sc-203623 sc-203623A | 10 mg 50 mg | $119.00 $670.00 | ||
LFM-A13 es un inhibidor de la cinasa tipo Polo, que podría influir indirectamente en la proteína centrosomal Kizuna a través de su acción sobre PLK1. | ||||||
Purvalanol B | 212844-54-7 | sc-361300 sc-361300A | 10 mg 50 mg | $199.00 $846.00 | ||
El Purvalanol A, un inhibidor de la cinasa dependiente de ciclina, puede afectar indirectamente a la Proteína Centrosomal Kizuna a través de vías de regulación del ciclo celular. | ||||||